Literature DB >> 9579962

Epilepsy in developing countries.

P Jallon1.   

Abstract

On June 6th and 7th, 1996, an international workshop on specific aspects of epilepsy in the developing world was organized in Geneva by the chairman of the ILAE Commission of Epilepsy in Developing Countries, P. Jallon, involving members of the ILAE, the World Health Organization (WHO), and a network of people who work with epilepsy patients in developing countries. Those taking part included all the members of the ILAE Commission on Epilepsy in Developing Countries, the chairmen of the ILAE Commissions on Tropical Diseases, Epidemiology, Education, Economics, and Drugs, as well as the president, treasurer, and past president of the ILAE; and the president of the IBE, Hanneke de Boer. There were representatives from Eastern European countries (Russia, Slovenia, Turkey), South America (Brazil, Colombia, Uruguay, Ecuador, Venezuela), Africa (Ethiopia, Senegal, South Africa, Togo, Tunisia), and Asia (India, Indonesia, Pakistan, Sri Lanka, The Philippines and China). Representatives from WHO joined the meeting on the last day (Drs. L. Prilipko, A. Janca, and C. L. Bolis). Three major topics were considered--epidemiology, medical assessment, and therapeutic aspects as well as some economic and social aspects of the disease. A second mission of this meeting was to work with WHO representatives to develop a program for action to care for people with epilepsy in these countries.

Entities:  

Mesh:

Year:  1997        PMID: 9579962     DOI: 10.1111/j.1528-1157.1997.tb01205.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  26 in total

1.  Neurocysticercosis.

Authors:  Christopher M DeGiorgio; Marco T Medina; Reyna Durón; Chi Zee; Susan Pietsch Escueta
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

2.  Pediatric neurology. Editorial.

Authors:  Pratibha Singhi
Journal:  Indian J Pediatr       Date:  2008-11       Impact factor: 1.967

3.  Influences of "spasmolytic powder" on pgp expression of Coriaria Lactone-kindling drug-resistant epileptic rat model.

Authors:  Lei Chen; Peimin Feng; Yaohua Li; Dong Zhou
Journal:  J Mol Neurosci       Date:  2012-12-20       Impact factor: 3.444

4.  Prevalence of neurocysticercosis among people with epilepsy in rural areas of Burkina Faso.

Authors:  Athanase Millogo; Pascal Nitiéma; Hélène Carabin; Marie Paule Boncoeur-Martel; Vedantam Rajshekhar; Zékiba Tarnagda; Nicolas Praet; Pierre Dorny; Linda Cowan; Rasmané Ganaba; Sennen Hounton; Pierre-Marie Preux; Rabiou Cissé
Journal:  Epilepsia       Date:  2012-11-13       Impact factor: 5.864

5.  Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis.

Authors:  Armandina Garza; David J Tweardy; Joel Weinstock; Balaji Viswanathan; Prema Robinson
Journal:  J Biomed Biotechnol       Date:  2010-01-28

6.  Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection.

Authors:  Armandina Garza; Joel Weinstock; Prema Robinson
Journal:  J Parasitol       Date:  2008-12       Impact factor: 1.276

Review 7.  Do helminths cause epilepsy?

Authors:  R G Wagner; C R Newton
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

8.  Phase-amplitude coupling and epileptogenesis in an animal model of mesial temporal lobe epilepsy.

Authors:  Soheila Samiee; Maxime Lévesque; Massimo Avoli; Sylvain Baillet
Journal:  Neurobiol Dis       Date:  2018-02-24       Impact factor: 5.996

Review 9.  The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies.

Authors:  Caroline K Mbuba; Anthony K Ngugi; Charles R Newton; Julie A Carter
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

10.  Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic.

Authors:  Michael Katwere; Andrew Kambugu; Theresa Piloya; Matthew Wong; Brett Hendel-Paterson; Merle A Sande; Allan Ronald; Elly Katabira; Edward M Were; Joris Menten; Robert Colebunders
Journal:  J Int AIDS Soc       Date:  2009-09-19       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.